Healthcare Sector Stocks
The Healthcare sector has a total of 1043 stocks, with a combined market cap of $8.99 trillion, total revenue of $4.6 trillion and a weighted average PE ratio of 50.37.
Market Cap
8.99T
Revenue
4.6T
Profits
178.45B
PE Ratio
50.37
Profit Margin
3.88%
Dividend Yield
0.38%
1043 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.05T | 2.68% | 2,419,133 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 652.31B | 0.56% | 6,323,815 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 468.50B | 0.02% | 3,457,948 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 365.09B | -0.07% | 10,328,311 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 336.61B | 1.00% | 4,651,716 | 450.53B |
| 6 | NVS | Novartis AG | 272.69B | 0.60% | 1,887,555 | 56.69B |
| 7 | TMO | Thermo Fisher Scientific Inc. | 250.83B | 1.97% | 2,097,943 | 46.34B |
| 8 | AMGN | Amgen Inc. | 219.52B | -0.01% | 2,524,955 | 38.10B |
| 9 | GILD | Gilead Sciences, Inc. | 185.61B | -1.11% | 5,074,725 | 30.46B |
| 10 | ABT | Abbott Laboratories | 174.89B | -2.34% | 6,216,645 | 46.59B |
| 11 | NVO | Novo Nordisk A/S | 170.16B | 1.18% | 20,079,604 | 50.34B |
| 12 | PFE | Pfizer Inc. | 161.93B | 0.82% | 34,774,743 | 63.70B |
| 13 | DHR | Danaher Corporation | 157.31B | 1.00% | 6,196,662 | 25.11B |
| 14 | ISRG | Intuitive Surgical, Inc. | 141.14B | 0.31% | 1,564,592 | 11.03B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 132.40B | 1.17% | 940,891 | 12.59B |
| 16 | BMY | Bristol-Myers Squibb Company | 125.63B | 0.57% | 14,902,836 | 49.19B |
| 17 | MDT | Medtronic plc | 113.22B | -0.88% | 10,967,728 | 37.54B |
| 18 | CVS | CVS Health Corporation | 108.78B | -0.94% | 7,382,468 | 412.65B |
| 19 | SYK | Stryker Corporation | 103.47B | -1.34% | 2,291,460 | 25.84B |
| 20 | MCK | McKesson Corporation | 101.36B | -1.27% | 593,676 | 410.98B |
| 21 | GSK | GSK plc | 99.42B | -0.12% | 2,838,966 | 44.05B |
| 22 | SNY | Sanofi | 98.20B | -1.73% | 3,070,353 | 55.89B |
| 23 | HCA | HCA Healthcare, Inc. | 91.68B | -2.98% | 1,050,688 | 78.01B |
| 24 | ELV | Elevance Health, Inc. | 86.37B | -0.08% | 1,169,493 | 201.11B |
| 25 | REGN | Regeneron Pharmaceuticals, Inc. | 79.49B | -0.72% | 600,620 | 15.53B |
| 26 | MRNA | Moderna, Inc. | 77.78B | 6.98% | 16,652,963 | 2.23B |
| 27 | CI | The Cigna Group | 70.16B | -1.03% | 1,611,949 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 64.75B | 0.13% | 17,296,722 | 21.00B |
| 29 | ARGX | argenx SE | 59.35B | 1.73% | 323,708 | 5.32B |
| 30 | COR | Cencora, Inc. | 59.13B | -0.77% | 1,081,434 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 59.11B | -1.17% | 3,256,915 | 28.42B |
| 32 | NTRA | Natera, Inc. | 58.92B | 4.61% | 1,963,683 | 2.71B |
| 33 | CAH | Cardinal Health, Inc. | 51.55B | 0.61% | 3,480,847 | 254.25B |
| 34 | EW | Edwards Lifesciences Corporation | 49.41B | -1.26% | 3,869,126 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 48.82B | -1.80% | 1,404,839 | 22.48B |
| 36 | A | Agilent Technologies, Inc. | 48.73B | 4.55% | 3,053,448 | 7.37B |
| 37 | TEVA | Teva Pharmaceutical Industries Limited | 46.87B | 3.10% | 7,731,632 | 17.32B |
| 38 | HUM | Humana Inc. | 45.67B | 1.48% | 898,998 | 145.68B |
| 39 | MDLN | Medline Inc. | 45.57B | 1.05% | 7,662,803 | 29.94B |
| 40 | IQV | IQVIA Holdings Inc. | 45.27B | 2.67% | 1,893,417 | 16.98B |
| 41 | VEEV | Veeva Systems Inc. | 44.50B | 1.51% | 1,379,930 | 3.46B |
| 42 | RVMD | Revolution Medicines, Inc. | 42.84B | 4.78% | 4,066,777 | - |
| 43 | WAT | Waters Corporation | 42.28B | 2.31% | 1,032,151 | 4.64B |
| 44 | ILMN | Illumina, Inc. | 41.36B | 7.25% | 3,445,102 | 4.49B |
| 45 | ONC | BeOne Medicines AG | 40.93B | -1.38% | 472,852 | 6.13B |
| 46 | IDXX | IDEXX Laboratories, Inc. | 40.45B | -1.65% | 328,281 | 4.55B |
| 47 | HLN | Haleon plc | 40.16B | 1.21% | 16,840,619 | 14.80B |
| 48 | RPRX | Royalty Pharma plc | 33.52B | 1.11% | 2,019,295 | 2.54B |
| 49 | BIIB | Biogen Inc. | 33.45B | -0.51% | 1,034,742 | 10.03B |
| 50 | ALNY | Alnylam Pharmaceuticals, Inc. | 33.40B | 1.25% | 933,715 | 4.80B |
| 51 | DXCM | DexCom, Inc. | 33.01B | -0.30% | 2,141,810 | 4.97B |
| 52 | RMD | ResMed Inc. | 31.74B | -0.18% | 798,773 | 5.65B |
| 53 | ALC | Alcon Inc. | 31.08B | -1.27% | 1,740,215 | 10.86B |
| 54 | CNC | Centene Corporation | 30.59B | -0.26% | 4,572,104 | 180.30B |
| 55 | MTD | Mettler-Toledo International Inc. | 30.44B | 1.80% | 260,918 | 4.13B |
| 56 | GEHC | GE HealthCare Technologies Inc. | 29.98B | 0.44% | 3,966,279 | 21.27B |
| 57 | ZTS | Zoetis Inc. | 29.04B | -1.87% | 3,372,118 | 9.53B |
| 58 | INSM | Insmed Incorporated | 26.54B | 2.71% | 2,233,027 | 1.14B |
| 59 | WST | West Pharmaceutical Services, Inc. | 26.29B | -0.60% | 715,925 | 3.33B |
| 60 | DGX | Quest Diagnostics Incorporated | 26.11B | 1.54% | 926,895 | 11.56B |
| 61 | ROIV | Roivant Sciences Ltd. | 26.10B | -1.87% | 5,659,867 | 7.53M |
| 62 | INCY | Incyte Corporation | 25.22B | -0.16% | 1,404,516 | 5.82B |
| 63 | LH | Labcorp Holdings Inc. | 25.06B | 1.63% | 784,939 | 14.35B |
| 64 | BNTX | BioNTech SE | 24.93B | 0.81% | 803,436 | 3.03B |
| 65 | PHG | Koninklijke Philips N.V. | 23.85B | 0.41% | 1,137,749 | 20.18B |
| 66 | GH | Guardant Health, Inc. | 23.68B | 0.08% | 2,565,862 | 1.18B |
| 67 | GMAB | Genmab A/S | 20.61B | 0.23% | 2,589,231 | 4.13B |
| 68 | STE | STERIS plc | 20.36B | -0.58% | 524,377 | 6.04B |
| 69 | UTHR | United Therapeutics Corporation | 20.25B | -3.52% | 570,299 | 3.15B |
| 70 | THC | Tenet Healthcare Corporation | 20.09B | -2.69% | 576,053 | 21.81B |
| 71 | VTRS | Viatris Inc. | 20.01B | 1.75% | 13,744,627 | 14.74B |
| 72 | MEDP | Medpace Holdings, Inc. | 17.32B | 0.56% | 308,864 | 2.78B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 17.11B | -1.31% | 2,646,386 | 8.51B |
| 74 | RVTY | Revvity, Inc. | 16.81B | 6.03% | 2,539,917 | 2.91B |
| 75 | JAZZ | Jazz Pharmaceuticals plc | 15.34B | 0.60% | 551,312 | 4.60B |
| 76 | ASND | Ascendis Pharma A/S | 15.15B | 3.39% | 1,165,609 | 1.20B |
| 77 | SOLV | Solventum Corporation | 15.08B | 0.25% | 635,841 | 8.31B |
| 78 | TEM | Tempus AI, Inc. | 14.84B | 7.38% | 10,821,334 | 1.43B |
| 79 | EXEL | Exelixis, Inc. | 14.36B | 2.15% | 1,925,738 | 2.44B |
| 80 | NBIX | Neurocrine Biosciences, Inc. | 14.12B | -0.39% | 1,169,276 | 3.37B |
| 81 | CRL | Charles River Laboratories International, Inc. | 14.06B | 6.17% | 1,590,820 | 4.00B |
| 82 | ICLR | ICON Public Limited Company | 13.42B | 6.10% | 1,619,309 | 8.29B |
| 83 | HALO | Halozyme Therapeutics, Inc. | 13.08B | 2.47% | 3,244,636 | 1.66B |
| 84 | SMMT | Summit Therapeutics Inc. | 13.07B | -0.43% | 5,045,314 | - |
| 85 | BBIO | BridgeBio Pharma, Inc. | 12.96B | 0.87% | 4,226,910 | 713.07M |
| 86 | CORT | Corcept Therapeutics Incorporated | 12.81B | 4.93% | 983,623 | 830.81M |
| 87 | PEN | Penumbra, Inc. | 12.59B | 0.09% | 482,950 | 1.50B |
| 88 | BAX | Baxter International Inc. | 12.14B | -0.04% | 7,346,049 | 11.47B |
| 89 | EHC | Encompass Health Corporation | 12.04B | -0.16% | 849,997 | 6.21B |
| 90 | BMRN | BioMarin Pharmaceutical Inc. | 11.88B | -1.38% | 1,659,441 | 3.41B |
| 91 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.86B | 0.04% | 219,343 | 1.28B |
| 92 | FMS | Fresenius Medical Care AG | 11.86B | -0.27% | 1,140,292 | 22.19B |
| 93 | BTSG | BrightSpring Health Services, Inc. | 11.67B | 0.43% | 2,430,497 | 14.37B |
| 94 | TWST | Twist Bioscience Corporation | 11.54B | 16.11% | 3,535,194 | 431.80M |
| 95 | TECH | Bio-Techne Corporation | 11.38B | 0.07% | 2,986,201 | 1.22B |
| 96 | SNN | Smith & Nephew plc | 11.17B | -0.52% | 1,485,033 | 6.30B |
| 97 | ELAN | Elanco Animal Health Incorporated | 11.17B | -0.97% | 7,643,637 | 5.02B |
| 98 | DVA | DaVita Inc. | 11.14B | -4.62% | 812,447 | 14.01B |
| 99 | TXG | 10x Genomics, Inc. | 10.96B | 11.23% | 4,096,631 | 616.91M |
| 100 | RGEN | Repligen Corporation | 10.76B | 3.32% | 1,602,602 | 785.10M |
| 101 | COO | The Cooper Companies, Inc. | 10.53B | -1.23% | 6,253,522 | 4.24B |
| 102 | UHS | Universal Health Services, Inc. | 10.43B | -2.43% | 890,360 | 18.11B |
| 103 | RDY | Dr. Reddy's Laboratories Limited | 10.42B | -0.73% | 3,036,574 | 3.50B |
| 104 | AVTR | Avantor, Inc. | 10.40B | 4.20% | 7,718,640 | 6.56B |
| 105 | BIO | Bio-Rad Laboratories, Inc. | 10.36B | 2.29% | 374,177 | 2.59B |
| 106 | ALGN | Align Technology, Inc. | 10.35B | -1.72% | 785,803 | 4.14B |
| 107 | AXSM | Axsome Therapeutics, Inc. | 10.27B | 1.33% | 386,149 | 776.57M |
| 108 | KRYS | Krystal Biotech, Inc. | 10.21B | 0.94% | 222,467 | 440.48M |
| 109 | MOH | Molina Healthcare, Inc. | 10.07B | 2.08% | 559,888 | 42.47B |
| 110 | ENSG | The Ensign Group, Inc. | 10.01B | -1.24% | 197,177 | 5.49B |
| 111 | GMED | Globus Medical, Inc. | 9.97B | 0.42% | 1,630,674 | 3.14B |
| 112 | BRKR | Bruker Corporation | 9.75B | 7.26% | 2,256,684 | 3.50B |
| 113 | KYMR | Kymera Therapeutics, Inc. | 9.63B | 0.29% | 841,723 | 105.00M |
| 114 | HSIC | Henry Schein, Inc. | 9.53B | 0.56% | 1,381,545 | 13.60B |
| 115 | PODD | Insulet Corporation | 9.42B | -0.52% | 1,085,421 | 3.05B |
| 116 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.33B | -1.33% | 1,626,304 | 669.50M |
| 117 | QGEN | Qiagen N.V. | 9.22B | 1.94% | 1,693,546 | 2.10B |
| 118 | IBRX | ImmunityBio, Inc. | 9.16B | 0.12% | 8,976,443 | 165.79M |
| 119 | GKOS | Glaukos Corporation | 9.13B | 0.91% | 838,399 | 612.84M |
| 120 | CYTK | Cytokinetics, Incorporated | 9.13B | -0.23% | 1,836,362 | 67.67M |
| 121 | CAI | Caris Life Sciences, Inc. | 9.12B | 1.96% | 5,982,289 | 989.61M |
| 122 | OSCR | Oscar Health, Inc. | 8.90B | -5.44% | 5,788,106 | 15.32B |
| 123 | PTGX | Protagonist Therapeutics, Inc. | 8.89B | -0.98% | 989,225 | 281.99M |
| 124 | PCVX | Vaxcyte, Inc. | 8.47B | 0.71% | 1,851,995 | - |
| 125 | TGTX | TG Therapeutics, Inc. | 8.16B | 2.71% | 1,138,335 | 799.54M |
| 126 | ABVX | ABIVAX Société Anonyme | 8.07B | 0.79% | 1,662,132 | 5.33M |
| 127 | PRAX | Praxis Precision Medicines, Inc. | 7.87B | -0.12% | 535,476 | 7.46M |
| 128 | ATR | AptarGroup, Inc. | 7.84B | -1.09% | 377,182 | 3.93B |
| 129 | SYRE | Spyre Therapeutics, Inc. | 7.68B | -1.22% | 1,729,587 | - |
| 130 | HNGE | Hinge Health, Inc. | 7.42B | -0.33% | 2,305,088 | 720.06M |
| 131 | HQY | HealthEquity, Inc. | 7.33B | -1.98% | 901,771 | 1.36B |
| 132 | IONS | Ionis Pharmaceuticals, Inc. | 7.28B | -0.27% | 6,448,794 | 874.09M |
| 133 | IMVT | Immunovant, Inc. | 7.02B | -1.56% | 1,479,998 | - |
| 134 | AMRX | Amneal Pharmaceuticals, Inc. | 6.90B | 2.46% | 1,664,993 | 3.12B |
| 135 | ALKS | Alkermes plc | 6.84B | -3.18% | 2,843,410 | 1.67B |
| 136 | HIMS | Hims & Hers Health, Inc. | 6.83B | 3.13% | 16,712,278 | 2.58B |
| 137 | BLTE | Belite Bio, Inc | 6.82B | 0.46% | 218,955 | - |
| 138 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.77B | 0.07% | 729,897 | 239.92M |
| 139 | PACS | PACS Group, Inc. | 6.56B | 1.00% | 518,705 | 5.55B |
| 140 | LNTH | Lantheus Holdings, Inc. | 6.51B | -0.25% | 938,543 | 1.56B |
| 141 | CHE | Chemed Corporation | 6.45B | -0.49% | 146,212 | 2.60B |
| 142 | GRFS | Grifols, S.A. | 6.39B | - | 536,149 | 8.48B |
| 143 | LQDA | Liquidia Corporation | 6.35B | 5.13% | 1,026,910 | 450.91M |
| 144 | CGON | CG Oncology, Inc. | 6.09B | -6.27% | 1,444,164 | 6.23M |
| 145 | BLCO | Bausch + Lomb Corporation | 6.00B | -1.47% | 170,721 | 5.32B |
| 146 | LGND | Ligand Pharmaceuticals Incorporated | 5.96B | 0.21% | 209,419 | 290.54M |
| 147 | SRRK | Scholar Rock Holding Corporation | 5.92B | -2.49% | 2,063,157 | - |
| 148 | BLLN | BillionToOne, Inc. | 5.89B | 9.16% | 998,271 | 397.41M |
| 149 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.88B | -0.97% | 433,344 | 840.85M |
| 150 | STVN | Stevanato Group S.p.A. | 5.84B | -1.43% | 191,737 | 1.40B |
| 151 | MIRM | Mirum Pharmaceuticals, Inc. | 5.80B | 0.04% | 681,378 | 618.07M |
| 152 | MMED | MiniMed Group, Inc. | 5.75B | -0.49% | 3,413,914 | 3.22B |
| 153 | TVTX | Travere Therapeutics, Inc. | 5.71B | 1.32% | 1,756,219 | 591.33M |
| 154 | ORKA | Oruka Therapeutics, Inc. | 5.66B | -4.94% | 1,294,347 | - |
| 155 | RDNT | RadNet, Inc. | 5.61B | -2.60% | 754,118 | 2.27B |
| 156 | GRAL | GRAIL, Inc. | 5.59B | 15.38% | 3,447,427 | 165.26M |
| 157 | COGT | Cogent Biosciences, Inc. | 5.46B | 0.06% | 2,591,463 | - |
| 158 | CRSP | CRISPR Therapeutics AG | 5.39B | -0.11% | 1,555,431 | 13.39M |
| 159 | SHC | Sotera Health Company | 5.27B | 0.87% | 1,323,604 | 1.22B |
| 160 | MMSI | Merit Medical Systems, Inc. | 5.21B | 0.26% | 846,589 | 1.58B |
| 161 | PTCT | PTC Therapeutics, Inc. | 5.20B | -0.10% | 1,754,258 | 1.01B |
| 162 | TFX | Teleflex Incorporated | 5.09B | -1.36% | 869,638 | 2.25B |
| 163 | ERAS | Erasca, Inc. | 5.08B | 4.09% | 6,266,567 | - |
| 164 | DNTH | Dianthus Therapeutics, Inc. | 5.07B | -2.92% | 726,358 | 1.90M |
| 165 | DFTX | Definium Therapeutics, Inc. | 4.94B | -2.44% | 2,308,995 | - |
| 166 | IOVA | Iovance Biotherapeutics, Inc. | 4.89B | 5.99% | 11,926,876 | 324.97M |
| 167 | MANE | Veradermics, Incorporated | 4.83B | -0.05% | 580,726 | - |
| 168 | HAE | Haemonetics Corporation | 4.82B | -0.77% | 416,799 | 1.35B |
| 169 | WAY | Waystar Holding Corp. | 4.72B | -0.48% | 1,124,624 | 1.21B |
| 170 | ADPT | Adaptive Biotechnologies Corporation | 4.72B | 6.02% | 3,610,530 | 308.08M |
| 171 | DOCS | Doximity, Inc. | 4.64B | -1.99% | 2,470,553 | 655.57M |
| 172 | LFST | LifeStance Health Group, Inc. | 4.51B | -2.32% | 4,255,642 | 1.58B |
| 173 | EWTX | Edgewise Therapeutics, Inc. | 4.47B | 0.27% | 1,378,742 | - |
| 174 | CON | Concentra Group Holdings Parent, Inc. | 4.41B | -0.49% | 841,384 | 2.29B |
| 175 | ITGR | Integer Holdings Corporation | 4.29B | -0.12% | 816,560 | 1.84B |
| 176 | VKTX | Viking Therapeutics, Inc. | 4.29B | -11.76% | 28,855,096 | - |
| 177 | HTFL | HeartFlow, Inc. | 4.23B | 2.68% | 1,515,773 | 212.07M |
| 178 | LIVN | LivaNova PLC | 4.16B | -2.23% | 1,056,361 | 1.47B |
| 179 | TNGX | Tango Therapeutics, Inc. | 4.15B | 0.74% | 2,290,573 | 53.81M |
| 180 | ICUI | ICU Medical, Inc. | 4.15B | 1.65% | 380,054 | 2.16B |
| 181 | ABCL | AbCellera Biologics Inc. | 4.10B | 2.76% | 4,990,522 | 66.17M |
| 182 | PBLS | Parabilis Medicines, Inc. | 4.01B | -2.52% | 1,166,097 | 148.00K |
| 183 | VCYT | Veracyte, Inc. | 3.90B | 10.77% | 2,880,354 | 561.90M |
| 184 | RLAY | Relay Therapeutics, Inc. | 3.89B | -1.66% | 3,675,976 | 10.35M |
| 185 | CELC | Celcuity Inc. | 3.88B | -0.78% | 1,237,732 | - |
| 186 | NVST | Envista Holdings Corporation | 3.87B | 1.05% | 2,541,389 | 2.86B |
| 187 | ACAD | ACADIA Pharmaceuticals Inc. | 3.82B | -12.78% | 6,761,623 | 1.14B |
| 188 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.78B | -1.54% | 1,420,273 | -665.00K |
| 189 | TLX | Telix Pharmaceuticals Limited | 3.75B | 0.35% | 830,213 | 890.79M |
| 190 | PLSE | Pulse Biosciences, Inc. | 3.70B | -0.29% | 666,867 | 1.19M |
| 191 | LEGN | Legend Biotech Corporation | 3.69B | 3.31% | 1,780,748 | 1.27B |
| 192 | XENE | Xenon Pharmaceuticals Inc. | 3.69B | 4.10% | 3,113,951 | 7.50M |
| 193 | IRTC | iRhythm Holdings, Inc. | 3.65B | -0.85% | 488,549 | 825.34M |
| 194 | OGN | Organon & Co. | 3.60B | -0.07% | 2,215,075 | 6.13B |
| 195 | IDYA | IDEAYA Biosciences, Inc. | 3.55B | -1.92% | 1,273,614 | 234.13M |
| 196 | NHC | National HealthCare Corporation | 3.47B | -1.45% | 84,374 | 1.56B |
| 197 | OPCH | Option Care Health, Inc. | 3.44B | -1.71% | 1,458,349 | 5.69B |
| 198 | TARS | Tarsus Pharmaceuticals, Inc. | 3.33B | 2.25% | 598,791 | 606.33M |
| 199 | ELVN | Enliven Therapeutics, Inc. | 3.31B | -2.19% | 749,355 | - |
| 200 | ARQT | Arcutis Biotherapeutics, Inc. | 3.30B | -0.42% | 2,177,536 | 463.98M |
| 201 | DNLI | Denali Therapeutics Inc. | 3.27B | 0.05% | 2,273,031 | 3.60M |
| 202 | WRBY | Warby Parker Inc. | 3.25B | 12.51% | 8,432,412 | 911.61M |
| 203 | RCUS | Arcus Biosciences, Inc. | 3.19B | -5.04% | 2,038,433 | 117.00M |
| 204 | CDNA | CareDx, Inc. | 3.17B | 13.00% | 2,501,407 | 458.09M |
| 205 | ATRC | AtriCure, Inc. | 3.09B | 1.35% | 1,305,131 | 569.62M |
| 206 | DYN | Dyne Therapeutics, Inc. | 3.08B | 1.73% | 3,197,665 | - |
| 207 | RGC | Regencell Bioscience Holdings Limited | 3.06B | 3.18% | 91,485 | - |
| 208 | NEOG | Neogen Corporation | 2.98B | 0.66% | 3,827,775 | 870.40M |
| 209 | TMDX | TransMedics Group, Inc. | 2.91B | -3.56% | 623,650 | 668.47M |
| 210 | ZLAB | Zai Lab Limited | 2.84B | -4.39% | 585,279 | 449.61M |
| 211 | PGEN | Precigen, Inc. | 2.76B | 3.49% | 4,617,834 | 85.72M |
| 212 | NAMS | NewAmsterdam Pharma Company N.V. | 2.72B | 0.26% | 1,824,112 | 7.12M |
| 213 | AVAH | Aveanna Healthcare Holdings Inc. | 2.70B | -3.21% | 4,961,338 | 2.60B |
| 214 | MBX | MBX Biosciences, Inc. | 2.67B | -4.32% | 638,964 | - |
| 215 | QURE | uniQure N.V. | 2.66B | -10.38% | 4,237,572 | 18.67M |
| 216 | GRDN | Guardian Pharmacy Services, Inc. | 2.65B | -3.40% | 494,443 | 1.46B |
| 217 | BKD | Brookdale Senior Living Inc. | 2.64B | -0.90% | 2,968,968 | 2.93B |
| 218 | WGS | GeneDx Holdings Corp. | 2.64B | 3.85% | 1,548,550 | 454.43M |
| 219 | ACHC | Acadia Healthcare Company, Inc. | 2.59B | -2.49% | 2,178,727 | 3.37B |
| 220 | GPCR | Structure Therapeutics Inc. | 2.57B | 0.19% | 2,110,906 | - |
| 221 | IRON | Disc Medicine, Inc. | 2.55B | 0.53% | 455,565 | - |
| 222 | AXGN | Axogen, Inc. | 2.54B | - | 796,645 | 251.17M |
| 223 | IMNM | Immunome, Inc. | 2.54B | -7.84% | 2,697,342 | 4.02M |
| 224 | SUPN | Supernus Pharmaceuticals, Inc. | 2.52B | -0.23% | 589,011 | 830.44M |
| 225 | NEO | NeoGenomics, Inc. | 2.51B | 6.54% | 2,948,467 | 766.30M |
| 226 | BFLY | Butterfly Network, Inc. | 2.51B | 2.28% | 5,305,090 | 112.14M |
| 227 | PRVA | Privia Health Group, Inc. | 2.48B | 1.52% | 1,484,724 | 2.36B |
| 228 | CLDX | Celldex Therapeutics, Inc. | 2.47B | 1.16% | 2,297,688 | 158.00K |
| 229 | BEAM | Beam Therapeutics Inc. | 2.46B | 1.19% | 2,284,237 | 156.04M |
| 230 | NRIX | Nurix Therapeutics, Inc. | 2.45B | -0.96% | 2,023,122 | 36.77M |
| 231 | SLS | SELLAS Life Sciences Group, Inc. | 2.42B | 3.99% | 4,652,593 | - |
| 232 | HCM | HUTCHMED (China) Limited | 2.41B | -2.71% | 44,296 | 549.12M |
| 233 | VERA | Vera Therapeutics, Inc. | 2.40B | 0.88% | 1,691,402 | - |
| 234 | HRMY | Harmony Biosciences Holdings, Inc. | 2.40B | 1.68% | 906,302 | 959.90M |
| 235 | CLOV | Clover Health Investments, Corp. | 2.40B | -1.31% | 3,199,904 | 2.48B |
| 236 | TRLV | Trulieve Cannabis Corp. | 2.36B | -2.15% | 1,731,316 | 1.14B |
| 237 | MLYS | Mineralys Therapeutics, Inc. | 2.35B | -1.12% | 895,377 | - |
| 238 | VRDN | Viridian Therapeutics, Inc. | 2.34B | -3.59% | 2,211,385 | 71.13M |
| 239 | PHVS | Pharvaris N.V. | 2.32B | -0.24% | 948,940 | - |
| 240 | UFPT | UFP Technologies, Inc. | 2.31B | 3.86% | 177,500 | 631.64M |
| 241 | ALMR | Alamar Biosciences, Inc. | 2.30B | 3.30% | 527,243 | 100.42M |
| 242 | AUPH | Aurinia Pharmaceuticals Inc. | 2.21B | 1.19% | 809,209 | 311.51M |
| 243 | SDGR | Schrödinger, Inc. | 2.20B | 0.75% | 2,028,479 | 259.04M |
| 244 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.18B | -0.58% | 4,853,755 | 940.61M |
| 245 | PBH | Prestige Consumer Healthcare Inc. | 2.16B | -0.59% | 627,211 | 1.10B |
| 246 | OCUL | Ocular Therapeutix, Inc. | 2.16B | -1.80% | 1,864,544 | 52.06M |
| 247 | ADMA | ADMA Biologics, Inc. | 2.13B | -1.86% | 2,586,546 | 512.28M |
| 248 | BHC | Bausch Health Companies Inc. | 2.11B | -1.05% | 2,020,478 | 10.85B |
| 249 | PVLA | Palvella Therapeutics, Inc. | 2.10B | -2.33% | 185,056 | - |
| 250 | ALVO | Alvotech | 2.10B | 1.20% | 1,198,733 | 494.61M |
| 251 | TRVI | Trevi Therapeutics, Inc. | 2.09B | 1.49% | 1,697,246 | - |
| 252 | ADUS | Addus HomeCare Corporation | 2.09B | -0.77% | 156,527 | 1.48B |
| 253 | RXRX | Recursion Pharmaceuticals, Inc. | 2.09B | 5.14% | 19,327,179 | 54.86M |
| 254 | KOD | Kodiak Sciences Inc. | 2.08B | 5.39% | 1,289,654 | - |
| 255 | GENB | Generate Biomedicines, Inc. | 2.05B | -3.21% | 1,438,061 | 26.48M |
| 256 | PRGO | Perrigo Company plc | 2.04B | 6.07% | 7,734,070 | 4.14B |
| 257 | MD | Pediatrix Medical Group, Inc. | 2.04B | -0.77% | 732,588 | 1.95B |
| 258 | NKTR | Nektar Therapeutics | 2.03B | 2.98% | 2,798,383 | 54.59M |
| 259 | URGN | UroGen Pharma Ltd. | 2.02B | -0.96% | 1,074,357 | 188.73M |
| 260 | VCEL | Vericel Corporation | 2.01B | 1.31% | 351,975 | 306.30M |
| 261 | NUVB | Nuvation Bio Inc. | 2.01B | 0.35% | 5,705,749 | 169.90M |
| 262 | MESO | Mesoblast Limited | 1.99B | 1.24% | 236,743 | 120.25M |
| 263 | PGNY | Progyny, Inc. | 1.99B | 0.54% | 1,332,716 | 1.31B |
| 264 | BHVN | Biohaven Ltd. | 1.99B | -3.51% | 3,025,720 | - |
| 265 | INSP | Inspire Medical Systems, Inc. | 1.99B | -0.36% | 580,634 | 898.74M |
| 266 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.99B | 3.80% | 2,392,673 | 208.78M |
| 267 | LKFT | Lakefront Biotherapeutics NV | 1.97B | -1.17% | 435,333 | 1.13B |
| 268 | AGIO | Agios Pharmaceuticals, Inc. | 1.96B | -3.77% | 1,635,129 | 98.34M |
| 269 | ESTA | Establishment Labs Holdings Inc. | 1.95B | -3.22% | 372,278 | 245.82M |
| 270 | SRPT | Sarepta Therapeutics, Inc. | 1.94B | -2.96% | 2,561,989 | 1.97B |
| 271 | FTRE | Fortrea Holdings Inc. | 1.90B | 2.61% | 1,225,678 | 2.68B |
| 272 | ZYME | Zymeworks Inc. | 1.90B | -2.51% | 752,933 | 37.13M |
| 273 | XRAY | DENTSPLY SIRONA Inc. | 1.90B | -2.56% | 3,736,419 | 3.64B |
| 274 | BLFS | BioLife Solutions, Inc. | 1.89B | 2.23% | 1,118,722 | 106.69M |
| 275 | NVCR | NovoCure Limited | 1.89B | -0.31% | 1,142,627 | 699.19M |
| 276 | LMAT | LeMaitre Vascular, Inc. | 1.85B | 0.30% | 321,253 | 262.43M |
| 277 | SGRY | Surgery Partners, Inc. | 1.84B | -2.47% | 2,029,365 | 3.37B |
| 278 | VIR | Vir Biotechnology, Inc. | 1.81B | -3.34% | 2,085,370 | 303.23M |
| 279 | CMPS | COMPASS Pathways plc | 1.81B | -4.80% | 3,915,399 | - |
| 280 | ZBIO | Zenas BioPharma, Inc. | 1.79B | -7.19% | 963,034 | 1.00M |
| 281 | SEPN | Septerna, Inc. | 1.78B | -0.83% | 293,140 | 98.88M |
| 282 | SNDA | Sonida Senior Living, Inc. | 1.78B | -0.58% | 401,292 | 481.07M |
| 283 | XNCR | Xencor, Inc. | 1.78B | -1.57% | 952,640 | 104.97M |
| 284 | ABSI | Absci Corporation | 1.78B | 6.10% | 3,388,022 | 1.56M |
| 285 | PSNL | Personalis, Inc. | 1.77B | 1.35% | 1,706,876 | 69.67M |
| 286 | ASTH | Astrana Health, Inc. | 1.76B | 0.29% | 391,466 | 3.84B |
| 287 | NVAX | Novavax, Inc. | 1.75B | 0.47% | 4,353,248 | 413.80M |
| 288 | FRNM | Freenome, Inc. | 1.72B | 1.97% | 507,520 | 35.41M |
| 289 | NTLA | Intellia Therapeutics, Inc. | 1.70B | -1.38% | 4,809,229 | 59.51M |
| 290 | ETON | Eton Pharmaceuticals, Inc. | 1.70B | 6.98% | 725,406 | 105.60M |
| 291 | KRSA | Korsana Biosciences, Inc. | 1.69B | 15.14% | 411,347 | - |
| 292 | GHRS | GH Research PLC | 1.68B | -5.82% | 418,140 | - |
| 293 | COAG | Hemab Therapeutics Holdings, Inc. | 1.67B | -2.64% | 401,281 | - |
| 294 | STOK | Stoke Therapeutics, Inc. | 1.63B | -3.14% | 1,220,367 | 27.59M |
| 295 | XERS | Xeris Biopharma Holdings, Inc. | 1.63B | 3.35% | 1,360,294 | 335.41M |
| 296 | RAPP | Rapport Therapeutics, Inc. | 1.62B | -0.88% | 848,705 | 20.00M |
| 297 | NBTX | Nanobiotix S.A. | 1.61B | -5.05% | 203,161 | 38.27M |
| 298 | IMCR | Immunocore Holdings plc | 1.61B | -0.70% | 640,552 | 430.78M |
| 299 | SNDX | Syndax Pharmaceuticals, Inc. | 1.60B | 1.87% | 2,068,732 | 252.25M |
| 300 | ALHC | Alignment Healthcare, Inc. | 1.59B | -2.42% | 15,935,456 | 4.58B |
| 301 | ANIP | ANI Pharmaceuticals, Inc. | 1.59B | -0.52% | 383,003 | 978.38M |
| 302 | TSHA | Taysha Gene Therapies, Inc. | 1.56B | -2.44% | 6,404,639 | 5.49M |
| 303 | KLRA | Kailera Therapeutics, Inc. | 1.55B | -8.76% | 2,762,260 | - |
| 304 | ANAB | AnaptysBio, Inc. | 1.55B | 1.83% | 417,781 | 106.09M |
| 305 | TYRA | Tyra Biosciences, Inc. | 1.54B | -3.53% | 1,090,085 | - |
| 306 | KMTS | Kestra Medical Technologies, Ltd. | 1.53B | 0.98% | 306,085 | 106.73M |
| 307 | BRVE | Braveheart Bio, Inc. | 1.53B | 8.90% | 396,653 | - |
| 308 | ATEC | Alphatec Holdings, Inc. | 1.53B | -1.10% | 1,664,552 | 815.05M |
| 309 | OMCL | Omnicell, Inc. | 1.51B | 0.12% | 499,531 | 1.25B |
| 310 | AZTA | Azenta, Inc. | 1.50B | 0.32% | 917,802 | 613.81M |
| 311 | INVA | Innoviva, Inc. | 1.49B | 2.08% | 1,368,075 | 440.00M |
| 312 | AVBP | ArriVent BioPharma, Inc. | 1.48B | -0.66% | 608,953 | - |
| 313 | ARDT | Ardent Health, Inc. | 1.48B | -1.50% | 470,712 | 6.41B |
| 314 | INBX | Inhibrx Biosciences, Inc. | 1.48B | 0.07% | 285,782 | 1.30M |
| 315 | OMER | Omeros Corporation | 1.46B | -2.94% | 909,686 | 38.42M |
| 316 | MAZE | Maze Therapeutics, Inc. | 1.46B | -6.69% | 789,176 | 20.00M |
| 317 | RARE | Ultragenyx Pharmaceutical Inc. | 1.45B | -0.74% | 3,492,906 | 717.00M |
| 318 | HCSG | Healthcare Services Group, Inc. | 1.44B | -1.32% | 936,584 | 1.86B |
| 319 | NUTX | Nutex Health Inc. | 1.40B | 1.35% | 136,814 | 846.72M |
| 320 | PNTG | The Pennant Group, Inc. | 1.38B | -0.05% | 301,965 | 1.10B |
| 321 | PAHC | Phibro Animal Health Corporation | 1.38B | -0.50% | 130,575 | 1.52B |
| 322 | ORIC | ORIC Pharmaceuticals, Inc. | 1.37B | -1.13% | 1,995,561 | - |
| 323 | AAPG | Ascentage Pharma Group International | 1.36B | -2.25% | 15,437 | 94.61M |
| 324 | DRTS | Alpha Tau Medical Ltd. | 1.36B | 1.72% | 468,684 | - |
| 325 | CERT | Certara, Inc. | 1.36B | 2.89% | 2,319,736 | 421.75M |
| 326 | CNMD | CONMED Corporation | 1.35B | -1.35% | 263,316 | 1.37B |
| 327 | KARD | Kardigan, Inc. | 1.35B | -0.90% | 862,411 | - |
| 328 | AMN | AMN Healthcare Services, Inc. | 1.34B | 1.92% | 920,399 | 3.43B |
| 329 | BCAX | Bicara Therapeutics Inc. | 1.31B | -3.47% | 1,374,214 | - |
| 330 | SVRA | Savara Inc. | 1.29B | 1.40% | 2,499,761 | - |
| 331 | TRAX | First Tracks Biotherapeutics, Inc. | 1.28B | -2.26% | 1,144,149 | - |
| 332 | AGL | agilon health, inc. | 1.27B | -10.32% | 374,712 | 5.92B |
| 333 | AVLN | Avalyn Pharma Inc. | 1.27B | -3.57% | 221,183 | - |
| 334 | DMRA | Damora Therapeutics, Inc. | 1.25B | -0.93% | 875,175 | - |
| 335 | USPH | U.S. Physical Therapy, Inc. | 1.25B | 1.34% | 175,665 | 804.27M |
| 336 | HROW | Harrow, Inc. | 1.24B | -1.49% | 397,795 | 275.59M |
| 337 | IART | Integra LifeSciences Holdings Corporation | 1.24B | 2.25% | 759,530 | 1.65B |
| 338 | OPK | OPKO Health, Inc. | 1.22B | -3.53% | 2,695,112 | 587.90M |
| 339 | CRON | Cronos Group Inc. | 1.22B | -2.35% | 721,206 | 179.09M |
| 340 | LBRX | LB Pharmaceuticals Inc | 1.22B | -3.55% | 413,497 | - |
| 341 | OMDA | Omada Health, Inc. | 1.21B | -4.69% | 962,505 | 309.76M |
| 342 | INNV | InnovAge Holding Corp. | 1.21B | -1.78% | 1,295,871 | 989.71M |
| 343 | REPL | Replimune Group, Inc. | 1.19B | -2.78% | 2,581,853 | - |
| 344 | LTGO | Latigo Biotherapeutics, Inc. | 1.18B | -11.07% | 340,659 | - |
| 345 | GDRX | GoodRx Holdings, Inc. | 1.15B | 1.20% | 879,453 | 785.23M |
| 346 | BBNX | Beta Bionics, Inc. | 1.15B | -1.94% | 906,850 | 119.01M |
| 347 | IMTX | Immatics N.V. | 1.14B | -3.14% | 2,372,895 | 47.65M |
| 348 | BVS | Bioventus Inc. | 1.14B | -0.66% | 331,450 | 581.85M |
| 349 | SPTX | Seaport Therapeutics, Inc. | 1.13B | -0.47% | 105,736 | - |
| 350 | AORT | Artivion, Inc. | 1.12B | -2.12% | 567,223 | 471.47M |
| 351 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.12B | 5.25% | 572,080 | 730.02M |
| 352 | TDOC | Teladoc Health, Inc. | 1.12B | 0.16% | 3,022,806 | 2.49B |
| 353 | AKTS | Aktis Oncology, Inc. | 1.09B | -0.46% | 384,952 | 10.06M |
| 354 | VOR | Vor Biopharma Inc. | 1.09B | -4.80% | 1,931,546 | - |
| 355 | IRMD | IRADIMED CORPORATION | 1.09B | -1.37% | 123,023 | 86.34M |
| 356 | CSTL | Castle Biosciences, Inc. | 1.08B | 0.89% | 439,150 | 357.28M |
| 357 | ANRO | Alto Neuroscience, Inc. | 1.07B | -1.16% | 788,422 | - |
| 358 | MGTX | MeiraGTx Holdings plc | 1.06B | -5.96% | 1,605,274 | 397.50M |
| 359 | TNDM | Tandem Diabetes Care, Inc. | 1.06B | -7.08% | 2,650,969 | 1.04B |
| 360 | MNKD | MannKind Corporation | 1.06B | -1.50% | 2,964,534 | 393.63M |
| 361 | ENOV | Enovis Corporation | 1.05B | 0.16% | 1,717,137 | 2.30B |
| 362 | MLTX | MoonLake Immunotherapeutics | 1.03B | -6.05% | 1,901,845 | - |
| 363 | JANX | Janux Therapeutics, Inc. | 1.02B | 0.97% | 1,301,926 | 24.00M |
| 364 | ANL | Adlai Nortye Group Ltd. | 1.02B | 0.70% | 144,252 | 18.06M |
| 365 | PCRX | Pacira BioSciences, Inc. | 1.02B | 3.78% | 725,132 | 746.16M |
| 366 | PRCT | PROCEPT BioRobotics Corporation | 1.00B | -3.26% | 1,351,980 | 337.34M |
| 367 | GLUE | Monte Rosa Therapeutics, Inc. | 999.87M | -1.43% | 1,143,775 | 28.73M |
| 368 | CGEM | Cullinan Therapeutics, Inc. | 993.64M | -8.48% | 2,728,827 | - |
| 369 | CRVS | Corvus Pharmaceuticals, Inc. | 992.63M | -5.90% | 1,143,025 | - |
| 370 | KURA | Kura Oncology, Inc. | 966.11M | -1.63% | 1,772,067 | 77.23M |
| 371 | ABUS | Arbutus Biopharma Corporation | 965.50M | 0.62% | 6,262,626 | 181.72M |
| 372 | STAA | STAAR Surgical Company | 956.75M | -3.64% | 880,087 | 339.59M |
| 373 | ODTX | Odyssey Therapeutics, Inc. | 955.01M | -4.00% | 395,998 | 99.00K |
| 374 | LMRI | Lumexa Imaging Holdings, Inc. | 949.22M | -2.56% | 326,152 | 1.04B |
| 375 | ALMS | Alumis Inc. | 943.58M | -2.02% | 2,605,339 | 7.40M |
| 376 | JBIO | Jade Biosciences, Inc. | 936.79M | 0.20% | 1,051,242 | - |
| 377 | SGP | SpyGlass Pharma, Inc. | 924.84M | -1.81% | 81,363 | - |
| 378 | HELP | Cybin Inc. | 919.83M | -3.30% | 1,459,104 | - |
| 379 | CBLL | CeriBell, Inc. | 914.17M | 0.85% | 215,080 | 101.96M |
| 380 | APMD | Apnimed, Inc. | 900.47M | -3.82% | 398,247 | 115.12M |
| 381 | RIGL | Rigel Pharmaceuticals, Inc. | 894.58M | -0.58% | 143,804 | 276.79M |
| 382 | SLBT | SL Science Holding Limited | 889.62M | -6.02% | 83,643 | 3.27M |
| 383 | SANA | Sana Biotechnology, Inc. | 886.11M | -3.90% | 3,509,293 | - |
| 384 | CADL | Candel Therapeutics, Inc. | 883.79M | 2.30% | 883,107 | - |
| 385 | HSTM | HealthStream, Inc. | 883.30M | 0.38% | 144,713 | 321.12M |
| 386 | ARDX | Ardelyx, Inc. | 859.70M | -0.86% | 3,233,585 | 450.89M |
| 387 | AVTX | Avalo Therapeutics, Inc. | 843.06M | 2.75% | 1,897,007 | 59.00K |
| 388 | IMMX | Immix Biopharma, Inc. | 837.01M | -1.85% | 1,535,833 | - |
| 389 | GMRS | GMR Solutions Inc. | 836.29M | -2.18% | 714,101 | 5.88B |
| 390 | SIBN | SI-BONE, Inc. | 830.04M | -0.43% | 630,207 | 213.60M |
| 391 | ATTO | Attovia Therapeutics, Inc. | 829.48M | -1.78% | 394,195 | 1.80M |
| 392 | OBX | Obsidian Therapeutics, Inc. | 828.37M | -12.12% | 426,596 | - |
| 393 | LXRX | Lexicon Pharmaceuticals, Inc. | 827.62M | -9.71% | 4,441,566 | 41.47M |
| 394 | INMD | InMode Ltd. | 815.65M | - | 439,564 | 374.63M |
| 395 | FDMT | 4D Molecular Therapeutics, Inc. | 812.64M | -1.93% | 1,768,227 | 92.01M |
| 396 | GERN | Geron Corporation | 809.52M | 1.61% | 6,413,404 | 204.56M |
| 397 | ACHV | Achieve Life Sciences, Inc. | 805.73M | - | 1,141,092 | - |
| 398 | SLDB | Solid Biosciences Inc. | 802.04M | -6.73% | 1,349,142 | - |
| 399 | ACRS | Aclaris Therapeutics, Inc. | 791.93M | 2.28% | 2,488,937 | 8.22M |
| 400 | OLMA | Olema Pharmaceuticals, Inc. | 790.98M | 2.38% | 1,486,201 | - |
| 401 | WVE | Wave Life Sciences, Inc. | 780.31M | 0.25% | 3,155,949 | 65.37M |
| 402 | VREX | Varex Imaging Corporation | 778.47M | 0.11% | 557,347 | 865.00M |
| 403 | GYRE | Gyre Therapeutics, Inc. | 777.23M | -0.95% | 327,686 | 109.82M |
| 404 | DSGN | Design Therapeutics, Inc. | 766.00M | -0.97% | 459,741 | - |
| 405 | FTH | Faeth Therapeutics, Inc. | 750.66M | -7.92% | 608,164 | - |
| 406 | AVR | Anteris Technologies Global Corp. | 745.56M | 0.39% | 777,766 | 2.24M |
| 407 | CTKB | Cytek Biosciences, Inc. | 744.80M | 0.88% | 1,595,455 | 206.71M |
| 408 | AHCO | AdaptHealth Corp. | 743.09M | -2.28% | 2,097,941 | 3.36B |
| 409 | IVA | Inventiva S.A. | 742.74M | -5.51% | 2,370,670 | 7.94M |
| 410 | ETRA | Electra Therapeutics, Inc. | 741.91M | -6.71% | 445,135 | - |
| 411 | COLL | Collegium Pharmaceutical, Inc. | 737.06M | 0.85% | 649,231 | 808.21M |
| 412 | PHAR | Pharming Group N.V. | 734.34M | -3.06% | 31,867 | 366.48M |
| 413 | QDEL | QuidelOrtho Corporation | 733.07M | 3.38% | 1,439,909 | 2.67B |
| 414 | ANNX | Annexon, Inc. | 720.40M | -1.81% | 2,022,748 | - |
| 415 | VSTM | Verastem, Inc. | 706.39M | -4.65% | 1,844,572 | 87.53M |
| 416 | NVCT | Nuvectis Pharma, Inc. | 704.74M | 2.99% | 258,187 | - |
| 417 | SOPH | SOPHiA GENETICS SA | 703.16M | 2.23% | 426,431 | 86.17M |
| 418 | OABI | OmniAb, Inc. | 696.42M | - | 1,044,897 | 38.46M |
| 419 | IRWD | Ironwood Pharmaceuticals, Inc. | 692.36M | -1.87% | 1,746,254 | 389.32M |
| 420 | DNA | Ginkgo Bioworks Holdings, Inc. | 690.24M | 19.46% | 4,029,650 | 132.42M |
| 421 | MDXG | MiMedx Group, Inc. | 686.53M | -1.26% | 1,021,799 | 355.17M |
| 422 | CLYM | Climb Bio, Inc. | 682.92M | -5.03% | 1,871,562 | - |
| 423 | SLN | Silence Therapeutics plc | 675.55M | -2.61% | 691,389 | 615.00K |
| 424 | GLAS | Glass House Brands Inc. | 673.83M | -8.92% | 1,837,377 | 176.98M |
| 425 | DBVT | DBV Technologies S.A. | 673.51M | -4.68% | 333,464 | 5.04M |
| 426 | ZVRA | Zevra Therapeutics, Inc. | 668.66M | -0.53% | 593,986 | 136.07M |
| 427 | STLN | Starling Oncology, Inc. | 663.47M | -4.55% | 1,762,296 | 587.24M |
| 428 | AHG | Akso Health Group | 651.10M | -1.29% | 11,549 | 13.83M |
| 429 | BLSM | BlossomHill Therapeutics, Inc. | 650.64M | -8.37% | 263,500 | - |
| 430 | AURA | Aura Biosciences, Inc. | 637.78M | 2.16% | 963,072 | - |
| 431 | STTK | Shattuck Labs, Inc. | 633.29M | -0.79% | 1,428,687 | 1.00M |
| 432 | ANGO | AngioDynamics, Inc. | 631.56M | -1.48% | 497,475 | 320.17M |
| 433 | NGNE | Neurogene Inc. | 625.36M | 1.03% | 374,881 | 925.00K |
| 434 | PHR | Phreesia, Inc. | 620.71M | 3.31% | 949,798 | 507.79M |
| 435 | CBIO | Crescent Biopharma, Inc. | 609.49M | 0.30% | 568,819 | 11.88M |
| 436 | CRMD | CorMedix Inc. | 605.63M | 1.04% | 946,415 | 462.25M |
| 437 | AQST | Aquestive Therapeutics, Inc. | 604.97M | 2.55% | 3,007,196 | 54.09M |
| 438 | CTMX | CytomX Therapeutics, Inc. | 599.22M | -1.08% | 3,081,444 | 18.30M |
| 439 | MPLT | MapLight Therapeutics, Inc. | 597.99M | -0.09% | 342,632 | - |
| 440 | MNPR | Monopar Therapeutics Inc. | 596.31M | -0.60% | 252,911 | - |
| 441 | FLGT | Fulgent Genetics, Inc. | 592.95M | 1.32% | 369,606 | 323.93M |
| 442 | ALT | Altimmune, Inc. | 591.33M | -4.70% | 3,685,835 | 31.00K |
| 443 | SSII | SS Innovations International, Inc. | 591.14M | -5.14% | 101,208 | 52.40M |
| 444 | KIDS | OrthoPediatrics Corp. | 591.13M | 1.39% | 105,866 | 252.72M |
| 445 | WEAV | Weave Communications, Inc. | 587.19M | -0.27% | 1,675,258 | 257.79M |
| 446 | OCS | Oculis Holding AG | 580.90M | -5.41% | 209,249 | 1.45M |
| 447 | ALLO | Allogene Therapeutics, Inc. | 576.97M | - | 7,790,082 | 4.64M |
| 448 | VALN | Valneva SE | 576.10M | -2.05% | 51,756 | 163.30M |
| 449 | SGMT | Sagimet Biosciences Inc. | 566.27M | -12.57% | 3,723,518 | - |
| 450 | PHAT | Phathom Pharmaceuticals, Inc. | 562.37M | 1.29% | 1,424,566 | 239.66M |
| 451 | DCTH | Delcath Systems, Inc. | 557.96M | 0.75% | 276,455 | 95.42M |
| 452 | TLRY | Tilray Brands, Inc. | 557.56M | -0.97% | 2,374,921 | 915.45M |
| 453 | EVO | Evotec SE | 556.53M | -1.30% | 29,765 | 819.47M |
| 454 | SENS | Senseonics Holdings, Inc. | 546.72M | 3.61% | 897,198 | 48.55M |
| 455 | PRME | Prime Medicine, Inc. | 546.17M | -1.92% | 4,483,573 | 4.07M |
| 456 | DRUG | Bright Minds Biosciences Inc. | 545.71M | -7.61% | 129,597 | - |
| 457 | EPRX | Eupraxia Pharmaceuticals Inc. | 535.72M | 0.25% | 452,889 | - |
| 458 | INDP | Indaptus Therapeutics, Inc. | 532.97M | 6.10% | 516,795 | - |
| 459 | BWAY | BrainsWay Ltd. | 527.37M | -1.78% | 65,802 | 60.70M |
| 460 | CERS | Cerus Corporation | 525.98M | 0.38% | 1,819,594 | 221.55M |
| 461 | AGMB | AgomAb Therapeutics NV | 521.04M | -1.76% | 64,174 | - |
| 462 | EOLS | Evolus, Inc. | 519.16M | -1.75% | 362,931 | 316.49M |
| 463 | TCMD | Tactile Systems Technology, Inc. | 518.51M | 2.05% | 175,039 | 350.31M |
| 464 | ARVN | Arvinas, Inc. | 509.36M | -0.51% | 1,218,005 | 316.70M |
| 465 | AUTL | Autolus Therapeutics plc | 508.37M | -2.05% | 1,819,209 | 117.39M |
| 466 | PROK | ProKidney Corp. | 507.90M | 1.82% | 1,726,689 | 818.00K |
| 467 | PBYI | Puma Biotechnology, Inc. | 506.91M | 5.82% | 467,384 | 231.24M |
| 468 | KMDA | Kamada Ltd. | 504.49M | 0.68% | 87,317 | 191.85M |
| 469 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 470 | TKNO | Alpha Teknova, Inc. | 498.76M | 4.03% | 356,213 | 43.70M |
| 471 | CAPR | Capricor Therapeutics, Inc. | 498.25M | -1.15% | 2,402,138 | 11.13M |
| 472 | PACB | Pacific Biosciences of California, Inc. | 491.11M | 12.06% | 11,100,917 | 159.27M |
| 473 | OVID | Ovid Therapeutics Inc. | 487.27M | -2.92% | 1,528,306 | 1.58M |
| 474 | ENTX | Entera Bio Ltd. | 484.80M | -0.36% | 233,999 | 42.00K |
| 475 | ASMB | Assembly Biosciences, Inc. | 481.73M | -1.29% | 178,991 | 74.85M |
| 476 | NPCE | NeuroPace, Inc. | 479.51M | -1.69% | 186,048 | 106.99M |
| 477 | SGHT | Sight Sciences, Inc. | 478.16M | 2.12% | 432,165 | 83.38M |
| 478 | RGNX | REGENXBIO Inc. | 477.94M | -3.47% | 1,515,858 | 174.48M |
| 479 | MASS | 908 Devices Inc. | 476.16M | 5.30% | 353,402 | 60.84M |
| 480 | TECX | Tectonic Therapeutic, Inc. | 471.53M | -3.44% | 214,409 | - |
| 481 | CTNM | Contineum Therapeutics, Inc. | 469.89M | -0.08% | 632,160 | - |
| 482 | SRTA | Strata Critical Medical, Inc. | 466.22M | -2.04% | 618,748 | 255.98M |
| 483 | NRC | NRC Health | 450.13M | -5.66% | 112,625 | 140.00M |
| 484 | EIKN | Eikon Therapeutics, Inc. | 449.03M | 1.97% | 710,106 | - |
| 485 | CLPT | ClearPoint Neuro, Inc. | 445.67M | -2.40% | 669,959 | 42.28M |
| 486 | KYTX | Kyverna Therapeutics, Inc. | 432.29M | -1.13% | 3,276,654 | - |
| 487 | PRTA | Prothena Corporation plc | 427.12M | -3.97% | 426,061 | 54.53M |
| 488 | EDIT | Editas Medicine, Inc. | 422.35M | 2.23% | 2,590,491 | 47.01M |
| 489 | DMAC | DiaMedica Therapeutics Inc. | 422.24M | 3.57% | 209,197 | - |
| 490 | AVIR | Atea Pharmaceuticals, Inc. | 414.66M | -2.08% | 228,793 | - |
| 491 | SPRY | ARS Pharmaceuticals, Inc. | 412.71M | -0.72% | 1,052,645 | 116.93M |
| 492 | RZLT | Rezolute, Inc. | 411.60M | -1.50% | 3,868,959 | - |
| 493 | PRLD | Prelude Therapeutics Incorporated | 410.95M | -7.42% | 1,040,074 | 22.42M |
| 494 | SCTX | Scribe Therapeutics Inc. | 409.11M | -18.55% | 525,430 | 33.30M |
| 495 | RLMD | Relmada Therapeutics, Inc. | 406.41M | 0.79% | 1,325,232 | - |
| 496 | IRD | Opus Genetics, Inc. | 405.16M | 0.83% | 1,830,806 | 9.86M |
| 497 | CARL | Carlsmed, Inc. | 404.63M | 0.41% | 45,212 | 63.30M |
| 498 | ARCT | Arcturus Therapeutics Holdings Inc. | 401.33M | 6.17% | 1,502,539 | 29.37M |
| 499 | GALT | Galectin Therapeutics Inc. | 399.36M | -2.22% | 153,301 | - |
| 500 | ZURA | Zura Bio Limited | 398.65M | -3.93% | 3,433,156 | - |